Ganesh V. Kaundinya
2017
In 2017, Ganesh V. Kaundinya earned a total compensation of $1.5M as Chief Operating Officer and Chief Scientific Officer at Momenta Pharmaceuticals, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,800 |
|---|---|
| Option Awards | $433,073 |
| Salary | $448,517 |
| Stock Awards | $425,068 |
| Other | $13,481 |
| Total | $1,516,939 |
Kaundinya received $448.5K in salary, accounting for 30% of the total pay in 2017.
Kaundinya also received $196.8K in non-equity incentive plan, $433.1K in option awards, $425.1K in stock awards and $13.5K in other compensation.
Rankings
In 2017, Ganesh V. Kaundinya's compensation ranked 6,929th out of 14,666 executives tracked by ExecPay. In other words, Kaundinya earned more than 52.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,929 out of 14,666 | 53rd |
Division Manufacturing | 2,567 out of 5,772 | 56th |
Major group Chemicals And Allied Products | 830 out of 2,075 | 60th |
Industry group Drugs | 644 out of 1,731 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 118 out of 313 | 62nd |
Source: SEC filing on April 27, 2018.
Kaundinya's colleagues
We found five more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2017.
2017
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2017
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
2017
Matthew Ottmer
Momenta Pharmaceuticals
Chief Operating Officer
2017
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2017
Scott Storer
Momenta Pharmaceuticals